DW4421-T1

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW4421-T1, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers [Phase 1]

See pricing